Why It's Inappropriate Not to Treat Incarcerated Patients with Opioid Agonist Therapy
Bibliographic Data
| ID | 15745571 |
|---|---|
| Authors | Sarah E Wakeman (0000-0002-5475-2713, Quality Enhancement Research Initiative, corresponding author) |
| Year | 2017 |
| Volume | 19 |
| Issue | 9 |
| Pages | 922-930 |
| Publication date | 2017-09-01 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | The AMA Journal of Ethic (JOURNAL) |
| Journal identifiers | ISSN: 2376-6980 • E-ISSN: 2376-6980 |
| Publisher | American Medical Association (PUBLISHER • US) |
| DOI | 10.1001/journalofethics.2017.19.9.stas1-1709 |
| PMID | 28905733 |
| OpenAlex | W2751297738 |
| Language | EN |
| Citations received | 8 |
| References cited | 11 |
Due to the criminalization of drug use and addiction, opioid use disorder is overrepresented in incarcerated populations. Decades of evidence supports opioid agonist therapy as a highly effective treatment that improves clinical outcomes and reduces illicit opioid use, overdose death, and cost. Opioid agonist therapy has been both studied within correctional facilities and initiated prerelease. It has been found to be beneficial, yet few incarcerated persons receive this evidence-based treatment. In addition to not offering treatment initiation for those who need it, most correctional facilities forcibly withdraw stable patients from opioid agonist therapy upon their entry into the criminal justice system. This approach limits their access to evidence-based health care and results in negative outcomes for individuals, communities, and society
Addiction · Agonist · Criminal justice · Criminalization · Criminology · Opioid · Opioid overdose · Opioid use disorder · Psychiatry · Medicine · Opioid Use Disorder Treatment · Prenatal Substance Exposure Effects · Psychology · Substance Abuse Treatment and Outcomes · Internal Medicine
Mal/adaptations
Opioid Agonist Treatment Recipients within Criminal Justice-Involved Populations
Ethical, clinical, and legal challenges of mental health care in prisons
Opioids and the Criminal Justice System
Psychiatric and legal considerations for ketamine treatment within prison settings
Ethical Imperatives to Overcome Stigma Against People With Substance Use Disorders
Comparing characteristics and outcomes of different opioid agonist treatment modalities among opioid-dependent federal men correctional populations in Canada
A Scoping Review of Barriers and Facilitators to Implementation of Medications for Treatment of Opioid Use Disorder within the Criminal Justice System
Accessing Antiretroviral Therapy Following Release From Prison
Mass incarceration, public health, and widening inequality in the USA
Medication-Assisted Therapies — Tackling the Opioid-Overdose Epidemic
Increases in Drug and Opioid-Involved Overdose Deaths — United States, 2010–2015
Jail Management of Arrestees/Inmates Enrolled in Community Methadone Maintenance Programs
When prisoners come home
The Health and Health Care of US Prisoners
Alcohol and Opiate Withdrawal in US Jails
Engaging Individuals Recently Released From Prison Into Primary Care
Termination of Medicaid Policies and Implications for the Affordable Care Act
Felon Disenfranchisement in the United States
| Unique citing works | 8 |
|---|---|
| Citations per year | 1,33 |
| Citation span | 2020 - 2026 (7) |
| Citation velocity | current |
| Highly cited | No |
| Citation types | Neutral: 7 |